Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 201-209

  Schmidt, Lars Henning ^a   Biesterfeld, Stefan ^b   Kümmel, Andreas ^a   Faldum, Andreas ^b   Sebastian, Martin ^a   Taube, Christian ^a   Buhl, Roland ^a   Wiewrodt, Rainer ^a,c  

^a Medical Clinic   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Concordance; Discordance; Immunohistochemistry; Multivariable analysis; Tissue microarray; Validity

Indexed keywords

CD174 ANTIBODY; CD227 ANTIBODY; MONOCLONAL ANTIBODY; MUCIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD GROUP LEWIS SYSTEM; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TISSUE CHARACTERIZATION; TISSUE MICROARRAY;

AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUCIN-1; PROGNOSIS; STAINING AND LABELING; TISSUE ARRAY ANALYSIS;

EID: 61449123216     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Alberg AJ, Brock MV and Samet JM: Epidemiology of lung cancer: looking to the future. J Clin Oncol 23(14): 3175-3185, 2005.
2. Apostolopoulos V and McKenzie IF: Cellular mucins: targets for immunotherapy. Crit Rev Immunol 14(3-4): 293-309, 1994.
3. Beasley MB, Brambilla E and Travis WD: The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 40(2): 90-97, 2005.
4. Berman JJ, Edgerton ME and Friedman BA: The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data. BMC Med Inform Decis Mak 3: 5, 2003.
5. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Mulis R and Lamport D: Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47(20): 5476-5482, 1987.
6. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S and Duhig T: A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer 44(4): 691-696, 1989.
7. Camp RL, Charette LA and Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest 80(12): 1943-1949, 2000.
8. Cao Y, Karsten U and Hilgers J: Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues. Tumour Biol 19(Suppl 1): 88-99, 1998.
9. Danielczyk A, Stahn R, Faulstich D, Loffler A, Marten A, Karsten U and Goletz S: PankoMab: a potent new generation anti-tumour MUC1 antibody. Cancer Immunol Immunother 55(11): 1337-1347, 2006.
10. Donati V, Faviana P, Dell'omodarme M, Prati MC, Camacci T, De IK, Giannini R, Lucchi M, Mussi A, Pingitore R, Basolo F and Fontanini G: Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer. Hum Pathol 35(11): 1347-1352, 2004.
11. Fong KM, Sekido Y, Gazdar AF and Minna JD: Lung cancer. 9: Molecular biology of lung cancer: clinical implications. Thorax 58(10): 892-900, 2003.
12. Gillett CE, Springall RJ, Barnes DM and Hanby AM: Multiple tissue core arrays in histopathology research: a validation study. J Pathol 192(4): 549-553, 2000.
13. Giltnane JM and Rimm DL: Technology insight: Identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 1(2): 104-111, 2004.
14. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C and Taylor-Papadimitriou J: A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43(6): 1072-1076, 1989.
15. Graham RA, Burchell JM and Taylor-Papadimitriou J: The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine. Cancer Immunol Immunother 42(2): 71-80, 1996.
16. Gulmann C, Butler D, Kay E, Grace A and Leader M: Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42(1): 70-76, 2003.
17. Hanisch FG, Muller S, Hassan H, Clausen H, Zachara N, Gooley AA, Paulsen H, Alving K and Peter-Katalinic J: Dynamic epigenetic regulation of initial O-glyco-sylation by UDP-N-acetylgalactosamine:peptide N-acetylgalactosaminyltransferases. Site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions. J Biol Chem 274(15): 9946-9954, 1999.
18. Hellstrom I, Garrigues HJ, Garrigues U and Hellstrom KE: Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res 50(7): 2183-2190, 1990.
19. Hendriks Y, Franken P, Dierssen JW, De LW, Wijnen J, Dreef E, Tops C, Breuning M, Brocker-Vriends A, Vasen H, Fodde R and Morreau H: Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 162(2): 469-477, 2003.
20. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ and Cordon-Cardo C: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158(4): 1245-1251, 2001.
21. Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de RM and Gilks CB: Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 15(12): 1374-1380, 2002.
22. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57(1): 43-66, 2007.
23. Kawai T, Suzuki M, Kase K and Ozeki Y: Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 72(5): 1581-1587, 1993.
24. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7): 844-847, 1998.
25. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B and Clement M: ABH and Lewis histo blood group antigens in cancer. APMIS 109(1): 9-31, 2001.
26. Leoni F, Colnaghi MI, Canevari S, Menard S, Colzani E, Facheris P, Figini M, Miotti S and Magnani JL: Glycolipids carrying Le(y) are preferentially expressed on small cell lung cancer cells as detected by the monoclonal antibody MLuCl. Int J Cancer 51(2): 225-231, 1992.
27. Leversha MA, Fielding P, Watson S, Gosney JR and Field JK: Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol 200(5): 610-619, 2003.
28. Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB and van de Rijn M: Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161(5): 1557-1565, 2002.
29. Lopez-Ferrer A, Curull V, Barranco C, Garrido M, Lloreta J, Real FX and de Bolos: Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 24(1): 22-29, 2001.
30. Mengel M, Kreipe H and von Wasielewski R: Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immunohistochem Mol Morphol 11(3): 261-268, 2003.
31. Mucci NR, Akdas G, Manely S and Rubin MA: Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 31(4): 406-414, 2000.
32. Nguyen PL, Niehans GA, Cherwitz DL, Kim YS and Ho SB: Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer. Tumour Biol 17(3): 176-192, 1996.
33. Nocito A, Kononen J, Kallioniemi OP and Sauter G: Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 94(1): 1-5, 2001.
34. O'Leary TJ: Standardization in immunohistochemistry. Appl Immunohistochem Mol Morphol 9(1): 3-8, 2001.
35. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108, 2005.
36. Peto R, Darby S, Deo H, Silcocks P, Whitley E and Doll R: Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321(7257): 323-329, 2000.
37. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8(3): 138-140, 1987.
38. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Anderson E, Bobrow LG and Miller KD: Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol 115(1): 44-58, 2001.
39. Rhodes A, Jasani B, Balaton AJ and Miller KD: Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in-house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 53(4): 292-301, 2000.
40. Rudiger T, Hofler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach FE, Fischer HP, Mengel M, von Wasielewski R and Muller-Hermelink HK: Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol 26(7): 873-882, 2002.
41. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Fieri F, Fraternali-Orcioni G and Pileri SA: The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51(7): 506-511, 1998.
42. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP and Sauter G: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5(8): 1966-1975, 1999.
43. Sharma-Oates A, Quirke P and Westhead DR: TmaDB: a repository for tissue microarray data. BMC Bioinformatics 6: 218, 2005.
44. Shi SR, Key ME and Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39(6): 741-748, 1991.
45. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80(9): 1803-1804, 1997.
46. Taylor-Papadimitriou J, Burchell J, Miles DW and Dalziel M: MUC1 and cancer. Biochim Biophys Acta 1455(2-3): 301-313, 1999.
47. Taylor-Papadimitriou J and Epenetos AA: Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol 12(6): 227-233, 1994.
48. van de Rijn M and Gilks CB: Applications of microarrays to histopathology. Histopathology 44(2): 97-108, 2004.
49. von Wasielewski R, Mengel M, Wiese B, Rudiger T, Muller-Hermelink HK and Kreipe H: Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 118(5): 675-682, 2002.
50. Vrolijk H, Sloos W, Mesker W, Franken P, Fodde R, Morreau H and Tanke H: Automated acquisition of stained tissue microarrays for high-throughput evaluation of molecular targets. J Mol Diagn 5(3): 160-167, 2003.
51. Wan WH, Fortuna MB and Furmanski P: A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 103(1): 121-129, 1987.
52. Yuriev E, Farrugia W, Scott AM and Ramsland PA: Three-dimensional structures of carbohydrate determinants of Lewis system antigens: implications for effective antibody targeting of cancer. Immunol Cell Biol 83(6): 709-717, 2005.
53. Zhang S, Zhang HS, Cordon-Cardo C, Reuter VE, Singhal AK, Lloyd KO and Livingston PO: Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int J Cancer 73(1): 50-56, 1997.